Logo
x

Search

Subscribe Now

Immunology

GC Publishes the Results of GC5107 in P-III Trial for the Treatment of Primary Immunodeficiency in Frontiers in Immunology

GC Publishes the Results of GC5107 in P-III Trial for the Treatment of Primary Immunodeficiency in Frontiers in Immunology

  • August 12, 2021
BMS Extends its 2019 Collaboration with Exscientia for AI Driven Drug Discovery

BMS Extends its 2019 Collaboration with Exscientia for AI Driven Drug Discovery

  • May 19, 2021
Samsung Bioepis Initiates P-I Study of SB17 Proposed Biosimilar to Stelara (ustekinumab)

Samsung Bioepis Initiates P-I Study of SB17 Proposed Biosimilar to Stelara (ustekinumab)

  • March 2, 2021
Pfizer Initiates Clinical Study of Eighth Candidate Emerges Under the Collaboration with Sosei Heptares

Pfizer Initiates Clinical Study of Eighth Candidate Emerges Under the Collaboration with Sosei Heptares

  • September 28, 2020
Top 20 Immunology Companies Based on 2018 Immunology Segment Revenue

Top 20 Immunology Companies Based on 2018 Immunology Segment Revenue

  • August 9, 2019
Sobi Acquires Novimmune's Emapalumab with its All Related Assets to Strengthen its Focus in Hematology and Immunology

Sobi Acquires Novimmune's Emapalumab with its All Related Assets to Strengthen its Focus in Hematology and Immunology

  • June 13, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.